NASDAQ$BIOX
Bioceres Crop Solutions Corp · Q2 2026 earnings
Q2 2026 earnings · · After market close · Investor relations
Briefing
Continuing ops profitable but $179M foreclosure loss drives massive quarterly deficit
Bioceres Crop Solutions reported unaudited interim results for the quarter ended December 31, 2025 with revenue from contracts of $73.7 million, down from $98.9 million in the prior-year quarter as crop protection and nutrition volumes softened. Continuing operations generated operating profit of $7.5 million, but a $179.0 million loss related to foreclosure of discontinued Pro Farm assets drove a total net loss of $182.5 million versus net income of $0.6 million a year ago. Continuing-operations net loss was $4.5 million compared with $6.7 million profit prior year, weighed by $8.0 million in financial costs. By segment, seed and integrated products revenue was $18.9 million (56% gross margin), crop protection $41.9 million (29% margin), and crop nutrition $13.0 million (31% margin).
- Q revenue $73.7M vs $98.9M prior year; H1 revenue $142.6M vs $182.3M
- Continuing ops operating profit $7.5M but net loss $4.5M on financial costs
- $179.0M foreclosure loss on discontinued Pro Farm operations drove total net loss of $182.5M
- Seed segment gross margin 56%; crop protection $41.9M revenue at 29% margin
- Cash declined to $11.1M from $32.7M at June 30, 2025
Headline financials
Revenue & EPS history
Bioceres · Revenue · Quarterly
$73.7M
Revenue by segment
Bioceres · $73.8M total across 3 segments · Q2 2026
- Crop protection$41.9M—56.8%
- Seed and Integrated Products$18.9M—25.6%
- Crop nutrition$13M—17.6%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2026
-0.9%
Avg return
Earnings day
-0.0%
Avg return
5 days after
-3.9%
Avg return
30 days after
41%
12 / 29 earnings
Positive
+12.6%
Q3 2023
Best reaction
-14.4%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -5.6% | -20.1% | -20.7% | |
| Q2 2026 | -9.2% | -12.8% | -16.0% | |
| Q3 2025 | -5.2% | -0.4% | -2.4% | |
| Q4 2024 | -14.4% | -15.2% | -26.2% | |
| Q3 2024 | -7.0% | -10.8% | -16.2% | |
| Q2 2024 | +4.0% | +3.1% | +1.5% | |
| Q1 2024 | +6.7% | +13.6% | +28.0% | |
| Q4 2023 | -2.3% | -0.4% | -4.1% | |
| Q3 2023 | +12.6% | +20.3% | +22.5% | |
| Q2 2023 | -8.4% | -2.4% | -6.8% | |
| Q1 2023 | +5.5% | +1.9% | -12.7% | |
| Q4 2022 | -2.9% | -2.9% | -10.3% | |
| Q3 2022 | +5.4% | +12.8% | +9.7% | |
| Q2 2022 | +1.8% | +1.4% | +19.1% | |
| Q1 2022 | +8.2% | +15.9% | +9.0% | |
| Q4 2021 | -6.5% | -8.2% | -2.2% | |
| Q3 2021 | +3.0% | +5.6% | -5.3% | |
| Q2 2021 | -1.9% | -1.7% | -7.5% | |
| Q1 2021 | -0.2% | -0.7% | -7.2% | |
| Q4 2020 | +4.8% | +7.0% | +17.9% | |
| Q3 2020 | -6.6% | -1.9% | -4.0% | |
| Q2 2020 | +4.7% | +13.5% | -12.5% | |
| Q1 2020 | -5.5% | -0.7% | -7.7% | |
| Q4 2019 | +0.0% | -7.4% | -6.6% | |
| Q3 2019 | -8.7% | -11.1% | -7.2% | |
| Q2 2019 | +0.2% | +0.2% | -47.4% | |
| Q1 2019 | +0.0% | +0.0% | +2.6% | |
| Q4 2018 | +0.2% | +0.0% | +0.2% | |
| Q3 2018 | +0.0% | +0.7% | +0.5% | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro